Cora H Ormseth1, Guido J Falcone1, Sara D Jasak1, David M Mampre1, Audrey C Leasure1, Laura C Miyares1, David Y Hwang1, Michael L James2, Fernando D Testai3, Kyra J Becker4, David L Tirschwell4, Carl D Langefeld5, Daniel Woo6, Kevin N Sheth7. 1. Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale School of Medicine, 15 York Street, LLCI Room 1003C, New Haven, CT, 06510, USA. 2. Departments of Anesthesiology and Neurology, Duke University, Durham, USA. 3. Departments of Neurology and Rehabilitation, University of Illinois at Chicago, Chicago, USA. 4. Department of Neurology, University of Washington, Seattle, USA. 5. Division of Public Health Sciences, Department of Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, USA. 6. Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, USA. 7. Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale School of Medicine, 15 York Street, LLCI Room 1003C, New Haven, CT, 06510, USA. kevin.sheth@yale.edu.
Abstract
BACKGROUND: Prior studies of patients in the intensive care unit have suggested racial/ethnic variation in end-of-life decision making. We sought to evaluate whether race/ethnicity modifies the implementation of comfort measures only status (CMOs) in patients with spontaneous, non-traumatic intracerebral hemorrhage (ICH). METHODS: We analyzed data from the Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study, a prospective cohort study specifically designed to enroll equal numbers of white, black, and Hispanic subjects. ICH patients aged ≥ 18 years were enrolled in ERICH at 42 hospitals in the USA from 2010 to 2015. Univariate and multivariate logistic regression analyses were implemented to evaluate the association between race/ethnicity and CMOs after adjustment for potential confounders. RESULTS: A total of 2705 ICH cases (912 black, 893 Hispanic, 900 white) were included in this study (mean age 62 [SD 14], female sex 1119 [41%]). CMOs patients comprised 276 (10%) of the entire cohort; of these, 64 (7%) were black, 79 (9%) Hispanic, and 133 (15%) white (univariate p < 0.001). In multivariate analysis, compared to whites, blacks were half as likely to be made CMOs (OR 0.50, 95% CI 0.34-0.75; p = 0.001), and no statistically significant difference was observed for Hispanics. All three racial/ethnic groups had similar mortality rates at discharge (whites 12%, blacks 9%, and Hispanics 10%; p = 0.108). Other factors independently associated with CMOs included age (p < 0.001), premorbid modified Rankin Scale (p < 0.001), dementia (p = 0.008), admission Glasgow Coma Scale (p = 0.009), hematoma volume (p < 0.001), intraventricular hematoma volume (p < 0.001), lobar (p = 0.032) and brainstem (p < 0.001) location and endotracheal intubation (p < 0.001). CONCLUSIONS: In ICH, black patients are less likely than white patients to have CMOs. However, in-hospital mortality is similar across all racial/ethnic groups. Further investigation is warranted to better understand the causes and implications of racial disparities in CMO decisions.
BACKGROUND: Prior studies of patients in the intensive care unit have suggested racial/ethnic variation in end-of-life decision making. We sought to evaluate whether race/ethnicity modifies the implementation of comfort measures only status (CMOs) in patients with spontaneous, non-traumatic intracerebral hemorrhage (ICH). METHODS: We analyzed data from the Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study, a prospective cohort study specifically designed to enroll equal numbers of white, black, and Hispanic subjects. ICHpatients aged ≥ 18 years were enrolled in ERICH at 42 hospitals in the USA from 2010 to 2015. Univariate and multivariate logistic regression analyses were implemented to evaluate the association between race/ethnicity and CMOs after adjustment for potential confounders. RESULTS: A total of 2705 ICH cases (912 black, 893 Hispanic, 900 white) were included in this study (mean age 62 [SD 14], female sex 1119 [41%]). CMOs patients comprised 276 (10%) of the entire cohort; of these, 64 (7%) were black, 79 (9%) Hispanic, and 133 (15%) white (univariate p < 0.001). In multivariate analysis, compared to whites, blacks were half as likely to be made CMOs (OR 0.50, 95% CI 0.34-0.75; p = 0.001), and no statistically significant difference was observed for Hispanics. All three racial/ethnic groups had similar mortality rates at discharge (whites 12%, blacks 9%, and Hispanics 10%; p = 0.108). Other factors independently associated with CMOs included age (p < 0.001), premorbid modified Rankin Scale (p < 0.001), dementia (p = 0.008), admission Glasgow Coma Scale (p = 0.009), hematoma volume (p < 0.001), intraventricular hematoma volume (p < 0.001), lobar (p = 0.032) and brainstem (p < 0.001) location and endotracheal intubation (p < 0.001). CONCLUSIONS: In ICH, black patients are less likely than white patients to have CMOs. However, in-hospital mortality is similar across all racial/ethnic groups. Further investigation is warranted to better understand the causes and implications of racial disparities in CMO decisions.
Entities:
Keywords:
End-of-life care; Intracerebral hemorrhage; Race and ethnicity
Authors: Xuemei Cai; Jennifer Robinson; Susanne Muehlschlegel; Douglas B White; Robert G Holloway; Kevin N Sheth; Liana Fraenkel; David Y Hwang Journal: Neurocrit Care Date: 2015-08 Impact factor: 3.210
Authors: Kevin N Sheth; Sharyl R Martini; Charles J Moomaw; Sebastian Koch; Mitchell S V Elkind; Gene Sung; Steven J Kittner; Michael Frankel; Jonathan Rosand; Carl D Langefeld; Mary E Comeau; Salina P Waddy; Jennifer Osborne; Daniel Woo Journal: Stroke Date: 2015-10-15 Impact factor: 7.914
Authors: Salvador Cruz-Flores; Alejandro Rabinstein; Jose Biller; Mitchell S V Elkind; Patrick Griffith; Philip B Gorelick; George Howard; Enrique C Leira; Lewis B Morgenstern; Bruce Ovbiagele; Eric Peterson; Wayne Rosamond; Brian Trimble; Amy L Valderrama Journal: Stroke Date: 2011-05-26 Impact factor: 7.914
Authors: Ramona L Rhodes; Bryan Elwood; Simon C Lee; Jasmin A Tiro; Ethan A Halm; Celette S Skinner Journal: Am J Hosp Palliat Care Date: 2016-02-14 Impact factor: 2.500
Authors: Roxanna M Garcia; Shyam Prabhakaran; Christopher T Richards; Andrew M Naidech; Matthew B Maas Journal: J Stroke Cerebrovasc Dis Date: 2019-12-12 Impact factor: 2.136
Authors: Chun Mei Su; Andrew Warren; Cassie Kraus; Wendy Macias-Konstantopoulos; Kori S Zachrison; Anand Viswanathan; Christopher Anderson; M Edip Gurol; Steven M Greenberg; Joshua N Goldstein Journal: Int J Emerg Med Date: 2021-01-19
Authors: Daniel Woo; Mary E Comeau; Simone Uniken Venema; Christopher D Anderson; Matthew Flaherty; Fernando Testai; Steven Kittner; Michael Frankel; Michael L James; Gene Sung; Mitchell Elkind; Bradford Worrall; Chelsea Kidwell; Nicole Gonzales; Sebastian Koch; Christiana Hall; Lee Birnbaum; Douglas Mayson; Bruce Coull; Marc Malkoff; Kevin N Sheth; Jacob L McCauley; Jennifer Osborne; Misty Morgan; Lee Gilkerson; Tyler Behymer; Elisheva R Coleman; Jonathan Rosand; Padmini Sekar; Charles J Moomaw; Carl D Langefeld Journal: JAMA Netw Open Date: 2022-03-01
Authors: Michael E Reznik; Scott Moody; Kayleigh Murray; Samantha Costa; Brian Mac Grory; Tracy E Madsen; Ali Mahta; Linda C Wendell; Bradford B Thompson; Shyam S Rao; Christoph Stretz; Kevin N Sheth; David Y Hwang; Darin B Zahuranec; Matthew Schrag; Lori A Daiello; Wael F Asaad; Richard N Jones; Karen L Furie Journal: Neurology Date: 2020-09-10 Impact factor: 9.910
Authors: Anisha Garg; Alexandria L Soto; Andrea K Knies; Stanislav Kolenikov; Marci Schalk; Heather Hammer; Douglas B White; Robert G Holloway; Kevin N Sheth; Liana Fraenkel; David Y Hwang Journal: Neurocrit Care Date: 2021-02-23 Impact factor: 3.532